Product NDC: | 0143-2125 |
Proprietary Name: | Chloroquine |
Non Proprietary Name: | Chloroquine Phosphate |
Active Ingredient(s): | 500 mg/1 & nbsp; Chloroquine Phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0143-2125 |
Labeler Name: | West-ward Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA083082 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990917 |
Package NDC: | 0143-2125-01 |
Package Description: | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (0143-2125-01) |
NDC Code | 0143-2125-01 |
Proprietary Name | Chloroquine |
Package Description | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (0143-2125-01) |
Product NDC | 0143-2125 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chloroquine Phosphate |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 19990917 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp |
Substance Name | CHLOROQUINE PHOSPHATE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antimalarial [EPC] |